<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        1009245892
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2009
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        EPIFENAC 75MG/3ML SOLUTION FOR INJECTION
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        DICLOFENAC SODIUM
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        25
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Parenteral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Solution for injection
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        3
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        3
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Ampoule
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        36
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        8.30
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="EIPICO" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            EIPICO
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 449]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Khalid Bin Saad Int. Company LTD
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            EIPICO
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        M01AB05
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Diclofenac sodium, the active ingredient in Epifenac ampoules, is one of a group of medicines called non-steroidal anti-inflammatory drugs (NSAIDs). NSAIDs reduce pain and inflammation.</p><p>The Epifenac ampoules is used to treat a number of painful conditions including:</p><p>- Flare-ups of joint or back pain.</p><p>- Attacks of gout.</p><p>- Pain caused by kidney stones.</p><p>- Pain caused by injuries.</p><p>Epifenac ampoules can either be given as an injection into the muscle, or as a slow infusion into a vein. The intravenous infusion is used in hospitals to prevent or treat pain following an operation.</p><p>Epifenac Ampoules are not suitable for children.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Some people must not have this injection. Talk to your doctor if:</p><p>- You think you may be allergic to diclofenac sodium, aspirin, ibuprofen or to any other NSAIDs, or to any of the other ingredients of Epifenac ampoules. (These are listed at the end of the leaflet). Signs of a hypersensitivity reaction include swelling of the face and mouth (angioedema), breathing problems, runny nose, skin rash or any other allergic type reactions.</p><p>- You have now, or have ever had, a stomach (gastric) or duodenal (peptic) ulcer, or</p><p>bleeding in the digestive tract (this can include blood in vomit, bleeding when emptying bowels, fresh blood in faeces or black, tarry faeces).</p><p>- You have had stomach or bowel problems after you have taken other NSAIDs.</p><p>- You have moderate or severe kidney or liver failure.</p><p>- You are pregnant.</p><p>- You have ischaemic heart disease.</p><p>- You have peripheral arterial disease.</p><p>- You have cerebrovascular disease.</p><p>- You have congestive heart failure (New York Heart Association [NYHA] classification II&ndash;IV).</p><p>Patients with these conditions should be switched to an alternative treatment at their next routine appointment.</p><p>Diclofenac treatment should only be initiated after careful consideration for patients with significant risk factors for cardiovascular events (e.g., hypertension, hyperlipidaemia, diabetes mellitus, smoking).</p><p>As the cardiovascular risks of diclofenac may increase with dose and duration of exposure, the lowest effective dose should be used for the shortest duration necessary to control symptoms. A patient&rsquo;s need for symptomatic relief and response to treatment should be re-evaluated periodically.</p><p>You should also ask yourself these questions before having an Epifenac ampoule:</p><p>- Do you suffer from any bowel disorders including ulcerative colitis or Crohn&#39;s disease?</p><p>- Do you have kidney or liver problems, or are you elderly?</p><p>- Do you suffer from any blood or bleeding disorder?</p><p>- Do you have a condition called porphyria?</p><p>- Have you ever had asthma?</p><p>- Are you breast-feeding?</p><p>- Do you have heart problems, or have you had a stroke, or do you think you might be at risk of these conditions (for example, if you have high blood pressure, diabetes or high cholesterol or are a smoker)?</p><p>- Do you have Lupus (SLE) or any similar condition?</p><p>- Could you be suffering from dehydration?</p><p>- Have you suffered any heavy loss of blood recently?</p><p>If the answer to any of these questions is YES, discuss your treatment with your doctor or pharmacist because Epifenac ampoules might not be the right medicine for you.</p><p>Pregnancy, nursing mothers &amp; pediatric use:</p><p>Do not administer injections preserved with benzyl alcohol to premature infants, neonates, pregnant women, or nursing mothers. Benzyl alcohol has been associated with serious adverse events &amp; death, particulary in pediatric patents. Injections preservative-free should be used in these population.</p><p>Are you taking other medicines?</p><p>Some medicines can interfere with your treatment. Tell your doctor or pharmacist if you are taking any of the following:</p><p>- Medicines to treat diabetes.</p><p>- Anticoagulants (blood thinning tablets like warfarin).</p><p>- Diuretics (water tablets).</p><p>- Lithium (used to treat some mental problems).</p><p>- Methotrexate (for some inflammatory diseases and some cancers).</p><p>- Ciclosporin and tacrolimus (used to treat some inflammatory diseases and after transplants).</p><p>- Quinolone antibiotics (for infections).</p><p>- Any other NSAIDs or COX-2 (cyclo-oxgenase-2) inhibitor, for example aspirin or ibuprofen.</p><p>- Mifepristone (a medicine used to terminate pregnancy).</p><p>- Cardiac glycosides (for example digoxin), used to treat heart problems.</p><p>- Medicines known as SSRIs used to treat depression.</p><p>- Oral steroids (an anti-inflammatory drug).</p><p>- Medicines used to treat heart conditions or high blood pressure, for example betablockers or ACE inhibitors.</p><p>- Sulfinpyrazone (a medicine used to treat gout) or voriconazole (a medicine used to treat fungal infections).</p><p>- Phenytoin (a medicine used to treat seizures).</p><p>Always tell your doctor or pharmacist about all the medicines you are taking. This means medicines you have bought yourself as well as medicines on prescription from your doctor.</p><p>Pregnancy:</p><p>- Are you pregnant or planning to become pregnant? Although not common, abnormalities have been reported in babies whose mothers have taken NSAIDs during pregnancy. You should not have Epifenac ampoules during pregnancy as it may affect the baby&rsquo;s circulation.</p><p>- Are you trying for a baby? Having Epifenac ampoules may make it more difficult to conceive. You should talk to your doctor if you are planning to become pregnant, or if you have problems getting pregnant.</p><p>Will there be any problems with driving or using machinery?</p><p>Very occasionally people have reported that Epifenac ampoules have made them feel dizzy, tired or sleepy. Problems with eyesight have also been reported. If you are affected in this way, you should not drive or operate machinery.</p><p>Other special warnings:</p><p>- You should take the lowest dose of Epifenac for the shortest possible time, particularly if you are underweight or elderly.</p><p>- There is a small increased risk of heart attack or stroke when you are taking any medicine like Epifenac. The risk is higher if you are taking high doses for a long time. Always follow the doctor&rsquo;s instructions on how much to take and how long to take it for.</p><p>- While you are taking these medicines your doctor may want to give you a check-up from time to time.</p><p>- If you have a history of stomach problems when you are taking NSAIDs, particularly if you are elderly, you must tell your doctor straight away if you notice any unusual symptoms.</p><p>- Because it is an anti-inflammatory medicine, Epifenac may reduce the symptoms of infection, for example, headache and high temperature. If you feel unwell and need to see a doctor, remember to tell him or her that you are taking Epifenac.</p><p>- Epifenac ampoules contain the preservative, sodium metabisulphite. This can sometimes cause allergic reactions and breathing difficulties.</p><p>- Epifenac ampoules should not be used in children.</p><p>- Epifenac ampoules contain benzyl alcohol which is potentially toxic when administered locally to neural tissue.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Your doctor will decide when and how to treat you with Epifenac ampoules. You will either be given an intravenous infusion (a drip into a vein) or an intramuscular injection (an injection into a muscle). The intramuscular injection is usually injected into the buttocks.</p><p>The usual dose is:</p><p>Adults: One or two ampoules (75 to 150 mg) each day for one or two days.</p><p>Elderly: Your doctor may give you a dose that is lower than the usual adult dose if you are elderly.</p><p>Children: Not suitable for children.</p><p>A doctor, nurse or pharmacist will prepare the injection for you.</p><p>If you have had an operation and are in hospital, the ampoule contents may be diluted and put into a drip bag before being given to you. A nurse or doctor will usually then give you the injection or infusion. You would not usually have to give the injection to yourself.</p><p>The doctor may also prescribe another drug to protect the stomach to be taken at the same time, particularly if you have had stomach problems before, or if you are elderly, or taking certain other drugs as well.</p><p>What if you have had too much Epifenac? (Overdose)</p><p>If you think you have been given too much Epifenac tell your doctor or nurse straight away.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Epifenac ampoules are suitable for most people, but, like all medicines, they can sometimes cause side effects.</p><p>Some side effects can be serious.</p><p>Tell the doctor straight away if you notice:</p><p>- Stomach pain, indigestion, heartburn, wind, nausea (feeling sick) or vomiting (being sick).</p><p>- Any sign of bleeding in the stomach or intestine, for example, when emptying your bowels, blood in vomit or black, tarry faeces.</p><p>- Allergic reactions which can include skin rash, itching, bruising, painful red areas, peeling or blistering.</p><p>- Wheezing or shortness of breath (bronchospasm).</p><p>- Swollen face, lips, hands or fingers.</p><p>- Yellowing of your skin or the whites of your eyes.</p><p>- Persistent sore throat or high temperature.</p><p>- An unexpected change in the amount of urine produced and/or its appearance.</p><p>If you notice that you are bruising more easily than usual or have frequent sore throats or infections, tell your doctor.</p><p>The side effects listed below have also been reported.</p><p>Up to 1 in 10 people have experienced:</p><p>Stomach pain, heartburn, nausea, vomiting, diarrhoea, indigestion, wind, loss of appetite, headache, dizziness, vertigo, skin rash or spots, raised levels of liver enzymes in the blood.</p><p>Between 1 in 100,000 and 1 in 100 people have experienced:</p><p>Stomach ulcers or bleeding (there have been very rare reported cases resulting in death, particularly in the elderly), drowsiness, tiredness, hypotension (low blood pressure, symptoms of which may include faintness, giddiness or light headedness), skin rash and itching, fluid retention, symptoms of which include swollen ankles, liver function disorders, including hepatitis and jaundice.</p><p>Isolated side effects, reported in less than 1 in 100,000 people include:</p><p>Effects on the nervous system:</p><p>Tingling or numbness in the fingers, tremor, blurred or double vision, hearing loss or impairment, tinnitus (ringing in the ears), sleeplessness, nightmares, mood changes, depression, anxiety, mental disorders, confusion, hallucinations, malaise, disorientation and loss of memory, fits, headaches together with a dislike of bright lights, fever and a stiff neck, disturbances in sensation.</p><p>Effects on the stomach and digestive system:</p><p>Constipation, inflammation of the tongue, mouth ulcers, taste changes, lower gut disorders (including inflammation of the colon).</p><p>Effects on the heart, chest or blood:</p><p>Palpitations (fast or irregular heart beat), chest pain, hypertension (high blood pressure), inflammation of blood vessels (vasculitis), inflammation of the lung (pneumonitis), congestive heart failure, blood disorders (including anaemia).</p><p>Effects on the liver or kidneys:</p><p>Kidney or liver disorders, presence of blood or protein in the urine.</p><p>Effects on skin or hair:</p><p>Serious skin rashes including Stevens-Johnson syndrome and Lyell&rsquo;s syndrome and other skin rashes which may be made worse by exposure to sunlight, hair loss.</p><p>Other effects:</p><p>Inflammation of the pancreas, impotence.</p><p>Medicines such as diclofenac may be associated with a small increased risk of heart attack or stroke.</p><p>Do not be alarmed by this list - most people have an injection of Epifenac without any problems.</p><p>If any of the symptoms become troublesome, or if you notice anything else not mentioned here, please go and see your doctor. He/she may want to give you a different medicine.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Store at a temprature not exceeding 30&deg;C.</p><p>Protect from light and heat.</p><p>Keep out of the reach and sight of children.</p><p>Do not use Epifenac ampoules after the expiry date which is printed on the outside of the pack.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>The active ingredient: Diclofenac sodium.</p><p>Each 3 ml contains 75 mg of diclofenac sodium.</p><p>The inactive ingredients: Propylene glycol, sodium metabisulphite, benzyl alcohol, mannitol, sodium hydroxide, water for injection.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Package:
Epifenac ampoules: Packs each of 3 ampoules.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Egyptian International Pharmaceutical Industries Company, E.I.P.I.CO.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                March 2015
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL" style="text-align:right">إن المادة الفعالة فى مستحضر إبيفيناك هى ديكلوفيناك الصوديوم، الذى ينتمى إلى مجموعة من الأدوية تسمى الأدوية الغير إستيرويدية المضادة للإلتهاب. إن الأدوية الغير إستيرويدية المضادة للإلتهاب تقلل من الألم والإلتهاب.</p><p dir="RTL" style="text-align:right">يستخدم إبيفيناك فى علاج عدد من الحالات المؤلمة بما فى ذلك:</p><p dir="RTL" style="text-align:right">- ألم المفاصل أو الظهر.</p><p dir="RTL" style="text-align:right">- نوبات النقرس.</p><p dir="RTL" style="text-align:right">- الألم الناجم عن حصوات الكلى.</p><p dir="RTL" style="text-align:right">- الألم الناجم عن الإصابات.</p><p dir="RTL" style="text-align:right">يمكن إعطاء إبيفيناك أمبول فى العضل، أو بالتسريب البطىء فى الوريد. يتم إستخدام الحقن بالتسريب الوريدى فى المستشفيات لمنع أو علاج الألم بعد العملية.</p><p>إن إبيفيناك أمبول غير مناسب للأطفال.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL" style="text-align:right">لا تستخدم إبيفيناك و تحدث إلى الطبيب إذا كنت:</p><p dir="RTL" style="text-align:right">- تعتقد أنك لديك حساسية من ديكلوفيناك الصوديوم، الأسبرين، إيبوبروفين أو من أى دواء آخر غير إستيرويدى مضاد للإلتهاب، أو من أى من المكونات الأخرى بالمستحضر. إن علامات فرط الحساسية تشمل تورم فى الوجه والفم (أوديما وعائية)، مشاكل فى التنفس، سيلان الأنف، طفح جلدى أو أى نوع آخر من تفاعلات الحساسية.</p><p dir="RTL" style="text-align:right">- لديك الآن ، أو سبق لك الإصابة بقرحة فى المعدة أو الإثنى عشر، أو بنزيف فى الجهاز الهضمى (وهذا يمكن أن يشمل تواجد دم فى القىء، والنزيف عند إفراغ الأمعاء، دماء فى البراز أو نزول براز أسود).</p><p dir="RTL" style="text-align:right">- لديك مشاكل فى المعدة أو الأمعاء بعد أخذ أدوية آخرى غير إستيرويدية مضادة للإلتهاب.</p><p dir="RTL" style="text-align:right">- لديك هبوط حاد فى القلب، الكلى أو الكبد.</p><p dir="RTL" style="text-align:right">- حاملا.</p><p dir="RTL" style="text-align:right">- تعانى من مرض بالقلب متعلق بقلة الدموية الموضعية.</p><p dir="RTL" style="text-align:right">- تعانى من مرض بالشرايين الطرفية.</p><p dir="RTL" style="text-align:right">- لديك مرض بالأوعية الدموية بالمخ.</p><p dir="RTL" style="text-align:right">- مصاب بفشل القلب الإحتقانى (جمعية القلب بنيويورك تصنيف II-IV).</p><p dir="RTL" style="text-align:right">يجب على الطبيب إختيار علاج بديل للمرضى الذين يعانون من الحالات السابقة فى الكشف الروتينى المقبل.</p><p dir="RTL" style="text-align:right">يجب عدم البدء فى العلاج بالديكلوفيناك إلا بعد دراسة متأنية فى المرضى العرضة لخطر للإصابة بحالات قلبية وعائية (مثل، إرتفاع ضغط الدم، فرط الدهون فى الدم، مرض السكر، والتدخين).</p><p dir="RTL" style="text-align:right">بما أن مخاطر الإصابة بحالات قلبية وعائية نتيجة العلاج بالديكلوفيناك تزداد بزيادة الجرعة و مدة العلاج، لذلك يجب إستخدام أقل جرعة فعالة لأقصر مدة لازمة للسيطرة على الأعراض. يجب إعادة تقييم إحتياج المريض لتخفيف الأعراض و مدى إستجابته للعلاج بشكل دورى.</p><p dir="RTL" style="text-align:right">يجب عليك أن تسأل نفسك هذه الأسئلة أيضا قبل أخذ إبيفيناك:</p><p dir="RTL" style="text-align:right">- هل تعانى من أى إضطرابات فى المعدة أو الأمعاء بما فيها إلتهاب القولون التقرحى أو مرض كرون؟</p><p dir="RTL" style="text-align:right">- هل لديك مشاكل فى الكلى أو الكبد، أو أنت من كبار السن؟</p><p dir="RTL" style="text-align:right">- هل أنت مصاب بحالة تسمى البورفيريا؟</p><p dir="RTL" style="text-align:right">- هل تعانى من أى إضطراب أو نزيف بالدم؟ إذا قمت بذلك، قد يطلب منك الطبيب الذهاب بشكل دورى لإجراء فحوصات أثناء العلاج بالدواء.</p><p dir="RTL" style="text-align:right">- هل سبق لك الإصابة بالربو؟</p><p dir="RTL" style="text-align:right">- هل أنت خلال فترة الرضاعة الطبيعية؟</p><p dir="RTL" style="text-align:right">- هل لديك مشاكل فى القلب، أو هل سبق لك الإصابة بسكتة دماغية، أو هل تعتقد أن هناك إمكانية فى أنت تصاب بهذه الحالات (على سبيل المثال، إذا كان لديك إرتفاع فى ضغط الدم أو مرض السكر أو إرتفاع فى نسبة الكوليسترول فى الدم أو مدخنا)؟</p><p dir="RTL" style="text-align:right">- هل أنت مصاب بمرض الذئبة (مرض الذئبة الحمراء) أو أى حالة مشابهة؟</p><p dir="RTL" style="text-align:right">- هل يمكن أن تكون مصاب بالجفاف؟</p><p dir="RTL" style="text-align:right">- هل سبق لك أن عانيت من أى خسائر فادحة فى الدم فى الآونة الأخيرة؟</p><p dir="RTL" style="text-align:right">إذا كانت الإجابة على أى من هذه الأسئلة هى نعم، يجب مراجعة الطبيب أو الصيدلى, لأن أمبولات إبيفيناك قد لا تكون الدواء المناسب لك.</p><p dir="RTL" style="text-align:right">الحمل و الرضاعة الطبيعية والأطفال:</p><p dir="RTL" style="text-align:right">لا يتم حقن دواء يحتوى على كحول بنزيلى كمادة حافظة فى الأطفال المبتسرين، حديثى الولادة، والنساء الحوامل أو المرضعات. حيث أن الكحول البنزيلى قد إرتبط بأحداث سلبية خطيرة و موت، وبخاصة فى المرضى الأطفال. لذلك يجب إستخدام حقن خالية من أى مواد حافظة فى هذه العمر.</p><p dir="RTL" style="text-align:right">تناول أدوية أخرى:</p><p dir="RTL" style="text-align:right">يمكن لبعض الأدوية أن تؤثر على طريقة عمل إبيفيناك. لذلك أخبر الطبيب أو الصيدلى إذا كنت تأخذ أى من الأدوية التالية:</p><p dir="RTL" style="text-align:right">- الأدوية المستخدمة لعلاج مرض السكر.</p><p dir="RTL" style="text-align:right">- الأدوية المضادة لتجلط الدم (مثل الوارفارين).</p><p dir="RTL" style="text-align:right">- مدرات البول.</p><p dir="RTL" style="text-align:right">- ليثيوم (المستخدم فى علاج بعض المشاكل النفسية).</p><p dir="RTL" style="text-align:right">- ميثوتركسات (لعلاج بعض الإلتهابات وبعض أنواع السرطان).</p><p dir="RTL" style="text-align:right">- سيكلوسبورين، تاكروليماس (المستخدم فى علاج بعض الإلتهابات وبعد عمليات زرع).</p><p dir="RTL" style="text-align:right">- المضادات الحيوية من نوع الكينولون (لعلاج العدوى).</p><p dir="RTL" style="text-align:right">- أى أدوية آخرى غير إستيرويدية مضادة للإلتهاب أو غيرها من مثبطات إنزيم سيكلواوكسجينيز- 2، مثل الأسبرين أو إيبوبروفين.</p><p dir="RTL" style="text-align:right">- ميفبريستون (وهو دواء يستخدم لإنهاء الحمل).</p><p dir="RTL" style="text-align:right">- الجليكوسيدات القلبية (مثل ديجوكسين)، والمستخدمة فى علاج مشاكل القلب.</p><p dir="RTL" style="text-align:right">- الأدوية المعروفة بإسم المثبطات الإنتقائية لإعادة إمتصاص السيروتينين المستخدمة فى علاج الإكتئاب.</p><p dir="RTL" style="text-align:right">- الإستيرويدات التى تؤخذ عن طريق الفم (الأدوية المضادة للإلتهاب).</p><p dir="RTL" style="text-align:right">- الأدوية المستخدمة فى علاج أمراض القلب أو إرتفاع ضغط الدم، مثل مغلقات المستقبلات بيتا أو مثبطات الإنزيم المحول للأنجيوتنسين.</p><p dir="RTL" style="text-align:right">- سلفينبيرازون (دواء يستخدم فى علاج النقرس) أو فوريكونازول (دواء يستخدم فى علاج العدوى الفطرية).</p><p dir="RTL" style="text-align:right">- فينيتوين (دواء يستخدم فى علاج النوبات).</p><p dir="RTL" style="text-align:right">يجب دائما إخبار طبيبك أو الصيدلى عن جميع الأدوية التى تتناولها. هذا يعنى الأدوية التى قد إشتريتها لنفسك وكذلك الأدوية التى تأخذها بناء على وصفة طبية من الطبيب.</p><p dir="RTL" style="text-align:right">الحمل:</p><p dir="RTL" style="text-align:right">هل أنت حاملا أو هناك نية للحمل؟ بالرغم من أنها غير شائعة، إلا أنه تم الإبلاغ عن تشوهات فى الأطفال الذين كانت أمهاتهم قد أخذت أدوية غير إستيرويدية مضادة للإلتهاب خلال فترة الحمل. لذلك يجب عدم أخذ إبيفيناك خلال الحمل لأنه قد يؤثر على الدورة الدموية للطفل.</p><p dir="RTL" style="text-align:right">هل تحاولين إنجاب طفل؟ إن أخذ إبيفيناك قد يجعل الأمر أكثر صعوبة. لذلك يجب التحدث مع طبيبك إذا كانت هناك نية للحمل، أو إذا كان لديك مشاكل فى أن تصبحين حاملا.</p><p dir="RTL" style="text-align:right">القيادة أو العمل أمام الماكينات:</p><p dir="RTL" style="text-align:right">لقد تم تسجيل فى كثير من الأحيان شعور بدوار أو تعب أو نعاس بعد أخذ إبيفيناك. و لقد تم أيضا تسجيل حدوث مشاكل فى البصر. إذا أصبت بالحالات السابقة، يجب عليك فى هذه الحالات عدم القيادة أو العمل أمام الماكينات.</p><p dir="RTL" style="text-align:right">تحذيرات خاصة أخرى:</p><p dir="RTL" style="text-align:right">- يجب أخذ أقل جرعة من إبيفيناك لأقصر وقت ممكن، خاصة إذا كنت تعانى من نقص فى الوزن أو من كبار السن.</p><p dir="RTL" style="text-align:right">- هناك خطر صغير متزايد من إمكانية الإصابة بنوبات قلبية أو سكتة دماغية عند أخذ أى دواء مثل إبيفيناك. و تزداد هذه الإمكانية عند أخذ جرعات عالية لفترة طويلة. لذلك إتبع دائما تعليمات الطبيب بخصوص كيفية أخذ الدواء و مدة العلاج.</p><p dir="RTL" style="text-align:right">- أثناء العلاج بهذه الأدوية طبيبك قد يرغب فى إجراء فحوصات عليك من وقت لآخر.</p><p dir="RTL" style="text-align:right">- إذا كان سبق لك الإصابة بمشاكل فى المعدة أثناء أخذ أدوية غير إستيرويدية مضادة للإلتهاب، خاصة إذا كنت من كبار السن، يجب عليك إخبار الطبيب فورا إذا لاحظت أى أعراض غير عادية.</p><p dir="RTL" style="text-align:right">- إن إبيفيناك دواء مضاد للإلتهاب، لذلك فقد يقلل من أعراض العدوى، مثل الصداع وإرتفاع درجة الحرارة. لذلك إذا كنت تشعر بتوعك، فإنك تحتاج إلى رؤية الطبيب، تذكر أن تخبر الطبيب أنك تأخذ إبيفيناك.</p><p dir="RTL" style="text-align:right">- إن إبيفيناك أمبول يحتوى على مادة حافظة تسمى صوديوم ميتا بايسالفيت. هذا يمكن أن يسبب أحيانا تفاعلات حساسية وصعوبة فى التنفس.</p><p dir="RTL" style="text-align:right">- لا ينبغى أن تستخدم أمبولات إبيفيناك فى الأطفال.</p><p>- إن إبيفيناك أمبول يحتوى على كحول بنزيلى الذى يمكن أن يكون سام عندما حقنه موضعيا فى الأنسجة العصبية.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL" style="text-align:right">سيحدد لك الطبيب كمية&nbsp; إبيفيناك الواجب أخذها و كيفية أخذها و مدة العلاج. إتبع دائما تعليمات الطبيب بعناية. إستمر فى أخذ الجرعة إلى أن يطلب منك الطبيب وقف العلاج، إلا إذا كان لديك أى مشاكل. فى هذه الحالة، إستشير الطبيب.</p><p dir="RTL" style="text-align:right">يتم إعطاء إبيفيناك أمبول إما عن طريق التسريب الوريدى أو الحقن العضلى. يتم عادة الحقن العضلى فى الأرداف.</p><p dir="RTL" style="text-align:right">الجرعات المعتادة:</p><p dir="RTL" style="text-align:right">البالغين:</p><p dir="RTL" style="text-align:right">1 &ndash; 2 أمبول (75 &ndash; 150 مجم) يوميا لمدة 1 &ndash; 2 يوم.</p><p dir="RTL" style="text-align:right">كبار السن:</p><p dir="RTL" style="text-align:right">قد ينصحك طبيبك بأخذ جرعة أقل من الجرعة المعتادة للبالغين إذا كنت من كبار السن.</p><p dir="RTL" style="text-align:right">الأطفال:</p><p dir="RTL" style="text-align:right">غير مناسب للأطفال.</p><p dir="RTL" style="text-align:right">إن الطبيب، الممرض أو الصيدلى هم فقط المسئولان عن إعطاءك الحقن.</p><p dir="RTL" style="text-align:right">إذا كنت قد أجريت عملية و أنت فى المستشفى، يمكن أن يتم تخفيف محتويات الأمبولة و وضعها فى كيس التنقيط قبل أن تعطى لك. ثم ستقوم الممرضة أو الطبيب عادة بإعطائك الحقنة عن طريق الحقن المباشر أو التسريب. و لن تحتاج غالبا إلى حقن نفسك.</p><p dir="RTL" style="text-align:right">قد يصف الطبيب أيضا دواء آخر لحماية المعدة يؤخذ فى نفس الوقت، لا سيما إذا كان لديك مشاكل فى المعدة من قبل، أو إذا كنت من كبار السن، أو كنت تأخذ بعض الأدوية الأخرى.</p><p dir="RTL" style="text-align:right">ماذا لو تناولت إبيفيناك أكثر من اللازم؟ (جرعة زائدة)</p><p>إذا كنت تعتقد أنك قد أعطيت الكثير من إبيفيناك أخبر طبيبك أو الممرضة على الفور.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL" style="text-align:right">مثل جميع الأدوية، يمكن أن يسبب إبيفيناك بعض الأعراض الجانبية، بالرغم من أنه ليس على جميع المرضى الإصابة بهذه الأعراض.</p><p dir="RTL" style="text-align:right">يمكن لبعض الآثار الجانبية أن تكون خطيرة.</p><p dir="RTL" style="text-align:right">توقف عن أخذ إبيفيناك و أخبر الطبيب فورا إذا لاحظت:</p><p dir="RTL" style="text-align:right">- ألم فى المعدة، عسر هضم، حرقان فى المعدة، ريح، غثيان أو قىء.</p><p dir="RTL" style="text-align:right">- أى علامة تفيد حدوث نزيف فى المعدة أو الأمعاء، مثل، عند تفريغ الأمعاء وجود دم فى القىء أو سواد فى البراز.</p><p dir="RTL" style="text-align:right">- تفاعلات حساسية يمكن أن تشمل طفح جلدى، حكة، كدمات، مناطق حمراء مؤلمة، تقشير أو ظهور تقرحات.</p><p dir="RTL" style="text-align:right">- صفير عند التنفس أو ضيق فى التنفس.</p><p dir="RTL" style="text-align:right">- تورم الوجه، الشفتين، اليدين أو الأصابع.</p><p dir="RTL" style="text-align:right">- إصفرار الجلد أو بياض العين.</p><p dir="RTL" style="text-align:right">- إلتهاب مستمر فى الحلق أو إرتفاع فى درجة الحرارة.</p><p dir="RTL" style="text-align:right">- تغيير غير متوقع فى كمية البول المنتجة و / أو مظهره.</p><p dir="RTL" style="text-align:right">إذا لاحظت أنك تصاب بسهولة بالكدمات بشكل أكبر من المعتاد أو إلتهاب متكرر فى الحلق أو عدوى متكررة، أخبر طبيبك على الفور.</p><p dir="RTL" style="text-align:right">لقد تم أيضا تسجيل الأعراض الجانبية التالية:</p><p dir="RTL" style="text-align:right">لقد تعرض ما يصل إلى شخص فى كل 10 أشخاص إلى:</p><p dir="RTL" style="text-align:right">- آلام فى المعدة، حرقان فى المعدة، غثيان، قىء، إسهال، عسر هضم، ريح، فقدان الشهية.</p><p dir="RTL" style="text-align:right">- صداع، دوخة، دوار.</p><p dir="RTL" style="text-align:right">- طفح جلدى أو بقع.</p><p dir="RTL" style="text-align:right">- إرتفاع مستوى إنزيمات الكبد فى الدم.</p><p dir="RTL" style="text-align:right">لقد تعرض ما بين شخص فى كل 100000 و شخص فى كل 100 شخص إلى:</p><p dir="RTL" style="text-align:right">- قرح أو نزيف فى المعدة (و فى حالات نادرة جدا كانت تؤدى إلى الوفاة، وبخاصة فى كبار السن).</p><p dir="RTL" style="text-align:right">- نعاس، تعب.</p><p dir="RTL" style="text-align:right">- إنخفاض فى ضغط الدم (أعراضه قد تشمل إغماء، دوخة أو صداع خفيف).</p><p dir="RTL" style="text-align:right">- طفح جلدى، حكة.</p><p dir="RTL" style="text-align:right">- إحتباس السوائل، والتى أعراضها تشمل تورم الكاحلين.</p><p dir="RTL" style="text-align:right">- إضطراب وظائف الكبد، بما فى ذلك إلتهاب الكبد و اليرقان.</p><p dir="RTL" style="text-align:right">الأعراض الجانبية المعزولة ، التى تم تسجيلها فى أقل من شخص فى كل 100000 شخصا ما يلى:</p><p dir="RTL" style="text-align:right">الجهاز العصبى المركزى:</p><p dir="RTL" style="text-align:right">وخز أو تخدير فى الأصابع، رعشة، عدم وضوح أو إزدواج الرؤية، فقدان أو إضطراب السمع، طنين (رنين فى الأذن)، أرق، كوابيس، تغير فى المزاج، إكتئاب، قلق، إضطرابات نفسية، إرتباك، هلوسة، فتور، توهان، فقدان الذاكرة، نوبات، صداع مع كره للأضواء الساطعة، حمى و تيبس العنق، إضطرابات فى الإحساس.</p><p dir="RTL" style="text-align:right">المعدة والجهاز الهضمى:</p><p dir="RTL" style="text-align:right">إمساك، إلتهاب اللسان، قرح بالفم، تغير الطعم، إضطرابات فى القناة الهضمية السفلية (بما فى ذلك إلتهاب القولون).</p><p dir="RTL" style="text-align:right">القلب، الصدر أو الدم:</p><p dir="RTL" style="text-align:right">خفقان (ضربات القلب سريعة أو غير منتظمة)، ألم فى الصدر، إرتفاع فى ضغط الدم، إلتهاب الأوعية الدموية، إلتهاب الرئة، قصور القلب الإحتقانى، إضطرابات فى الدم (بما فى ذلك فقر الدم).</p><p dir="RTL" style="text-align:right">الكبد أو الكلى:</p><p dir="RTL" style="text-align:right">إضطرابات فى الكلى أو الكبد، وجود دم أو بروتين فى البول.</p><p dir="RTL" style="text-align:right">الجلد أو الشعر:</p><p dir="RTL" style="text-align:right">طفح جلدى خطير بما فى ذلك متلازمة ستيفنز جونسون ومتلازمة ليل و أنواع آخرى من الطفح الجلدى التى قد تزداد سوءا بسبب التعرض لأشعة الشمس.</p><p dir="RTL" style="text-align:right">تساقط الشعر.</p><p dir="RTL" style="text-align:right">من الأعراض الجانبية الآخرى:</p><p dir="RTL" style="text-align:right">إلتهاب البنكرياس، عقم.</p><p dir="RTL" style="text-align:right">إن أدوية مثل ديكلوفيناك قد يرافق أخذها زيادة صغيرة فى إمكانية الإصابة بأزمة قلبية أو جلطة.</p><p dir="RTL" style="text-align:right">لا تشعر بالذعر من هذه القائمة، فإن معظم الناس يأخذون إبيفيناك دون حدوث أى مشاكل.</p><p>يجب إخبار الطبيب أو الصيدلى فور ملاحظة أن الأعراض الجانبية تزداد سوءا أو عند حدوث أعراض جانبية غير مسجلة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL" style="text-align:right">تحفظ فى درجة حرارة لا تزيد عن 30 &deg;م.</p><p dir="RTL" style="text-align:right">يحفظ الدواء بعيدا عن متناول الأطفال.</p><p dir="RTL" style="text-align:right">يجب عدم أخذ إبيفيناك بعد إنتهاء تاريخ الصلاحية المكتوب على العلبة، و يشير تاريخ إنتهاء الصلاحية إلى آخر يوم فى الشهر المذكور.</p><p>يجب عدم التخلص من الدواء عن طريق مياة المجارى أو عن طريق القمامة. و يجب إستشارة الصيدلى عن كيفية التخلص من الدواء الغير مستخدم، و الهدف من ذلك المحافظة على البيئة نظيفة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL" style="text-align:right">المادة الفعالة: ديكلوفيناك الصوديوم.</p><p dir="RTL" style="text-align:right">كل 3 مل تحتوى على 75 مجم ديكلوفيناك الصوديوم .</p><p>المواد الغير فعالة: بروبيلين جليكول، صوديوم ميتا بايسالفيت، كحول بنزيلى، مانيتول، هيدروكسيد الصوديوم، ماء للحقن.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL" style="text-align:right">العبوة:</p><p>علبة بها 3 أمبولات.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p>الشركة المصرية الدولية للصناعات الدوائية (إيبيكو)</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            مارس 2015
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Epifenac Ampoule (3 ml) 75 gm
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Each ampoule contains:
Diclofenac sodium 75 gm
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Colorless to slightly yellow sterile solution, filled in an amber glass ampoules.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Adults and Elderly:<br />Relief of all grades of pain and inflammation in a wide range of conditions, including:<br />-Arthritic conditions: rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, acute gout.<br />-Acute musculo-skeletal disorders such as periarthritis (for example frozen shoulder), tendinitis, tenosynovitis, bursitis.<br />-Other painful conditions resulting from trauma, including fracture, low back pain, sprains, strains, dislocations, orthopaedic, dental and other minor surgery, renal colic.<br />Ampoules used in intravenous infusion:<br />For treatment or prevention of post-operative pain in the hospital setting.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Undesirable effects may be minimised by using the lowest effective dose for the shortest duration necessary to control symptoms.<br />EPIFENAC ampoules (given im or iv) should not be given for more than two days; if necessary, treatment can be continued with EPIFENAC tablets or suppositories.<br />Intramuscular injection:The following directions for intramuscular injection must be adhered to in order to avoid damage to a nerve or other tissue at the injection site.<br />One ampoule once (or in severe cases twice) daily intramuscularly by deep intragluteal injection into the upper outer quadrant.If two injections daily are required it is advised that the alternative buttock be used for the second injection.Alternatively, one ampoule of 75 mg can be combined with other dosage forms of EPIFENAC (tablets or suppositories) up to the maximum daily dosage of 150 mg.</p><p>Renal colic: One 75 mg ampoule intramuscularly.A further ampoule may be administered after 30 minutes if necessary.The recommended maximum daily dose of EPIFENAC is 150 mg.<br />Intravenous Infusion: Immediately before initiating an intravenous infusion, EPIFENAC must be diluted with 100 - 500 ml of either sodium chloride solution (0.9%) or glucose solution (5%). Both solutions should be buffered with sodium bicarbonate solution (0.5 ml 8.4% or 1 ml 4.2%). Only clear solutions should be used.<br />EPIFENAC must not be given as an intravenous bolus injection.<br />Two alternative regimens are recommended:<br />For the treatment of moderate to severe post-operative pain, 75 mg should be infused continuously over a period of 30 minutes to 2 hours.If necessary, treatment may be repeated after 4 - 6 hours, not exceeding 150 mg within any period of 24 hours.<br />For the prevention of post-operative pain, a loading dose of 25 - 50 mg should be infused after surgery over 15 minutes to 1 hour, followed by a continuous infusion of approx.<br />5 mg per hour up to a maximum daily dosage of 150 mg.<br />Children:<br />EPIFENAC ampoules are not recommended for use in children.<br />Elderly: Although the pharmacokinetics of EPIFENAC are not impaired to any clinically relevant extent in elderly patients, nonsteroidal anti-inflammatory drugs should be used with particular caution in such patients who generally are more prone to adverse reactions.In particular it is recommended that the lowest effective dosage be used in frail elderly patients or those with a low body weight and the patient should be monitored for GI bleeding during NSAID therapy.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                -Hypersensitivity to the active substance or any of the excipients.
-Patients with active, or a history of, gastrointestinal ulcers, bleeding or perforation (two or more distinct episodes of proven ulceration or bleeding).
-Patients who have previously shown hypersensitivity reactions (e.g. asthma, angioedema, urticaria or acute rhinitis) to ibuprofen, aspirin or other nonsteroidal anti-inflammatory drugs.
-Severe hepatic, renal and heart failure (see Special warnings and precautions for use).
-History of gastrointestinal bleeding or perforation, relating to previous NSAID therapy.
EPIFENAC is contraindicated in children less than 6 years.
Diclofenac is now contraindicated in patients with established:
- ischaemic heart disease
- peripheral arterial disease
- cerebrovascular disease
- congestive heart failure (New York Heart Association
[NYHA] classification II–IV)
Specifically for iv use.
-Concomitant NSAID or anticoagulant use (including low dose heparin).
-History of haemorrhagic diathesis, a history of confirmed or suspected cerebrovascular bleeding.
-Operations associated with a high risk of haemorrhage.
-A history of asthma.
-Moderate or severe renal impairment (serum creatinine >160 μmol/l).
-Hypovolaemia or dehydration from any cause.
Pregnancy, nursing mothers & pediatric use:
Do not administer injections preserved with benzyl alcohol to premature infants, neonates, infants below 13 years, pregnant women, or nursing mothers.Benzyl alcohol has been associated with serious adverse events & death, particulary in pediatric patents (it may cause Gasping syndrome).Injections preservative free should be used in these population.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Warnings:<br />In all patients:<br />Undesirable effects may be minimised by using the lowest effective dose for the shortest duration necessary to control symptoms.<br />The use of EPIFENAC with concomitant NSAIDs including cyclooxygenase-2 selective inhibitors should be avoided.<br />Diclofenac treatment should only be initiated after careful consideration for patients with significant risk factors for cardiovascular events (eg, hypertension, hyperlipidaemia, diabetes mellitus, smoking).<br />As the cardiovascular risks of diclofenac may increasewith doseand duration of exposure, the lowest effective dose should be used for the shortest duration necessary to control symptoms. A patient&rsquo;s need for symptomatic relief and response to treatment should be re-evaluated periodically.<br />Elderly: The elderly have increased frequency of adverse reactions to NSAIDs especially gastro intestinal bleeding and perforation which may be fatal.<br />Gastrointestinal: As with all NSAIDs, including diclofenac close medical surveillance is imperative in patients with symptoms indicative of gastrointestinal disorders, with a history suggestive of gastric or intestinal ulceration, with ulcerative colitis, or with Crohn&#39;s disease as these conditions may be exacerbated.<br />Patients with a history of GI toxicity, particularly when elderly, should report any unusual abdominal symptoms (especially GI bleeding).<br />Gastrointestinal bleeding or ulceration/perforation: haematemesis melaena ulceration or perforation which can be fatal has been reported with all NSAIDs including diclofenac. They can occur at any time during treatment, with or without warning symptoms or a previous history of serious GI events. In the rare instances when gastrointestinal bleeding or ulceration occurs in patients receiving EPIFENAC, the drug should be withdrawn.<br />The risk of GI bleeding, ulceration or perforation is higher with increasing NSAID doses including diclofenac, in patients with a history of ulcer, particularly if complicated with haemorrhage or perforation, and in the elderly.These patients should commence treatment on the lowest dose available. Combination therapy with protective agents (e.g. misoprostol or proton pump inhibitors) should be considered for these patients, and also for patients requiring concomitant low dose aspirin, other drugs likely to increase gastrointestinal risk.<br />Caution should be advised in patients receiving concomitant medications which could increase the risk of ulceration or bleeding, such as oral corticosteroids, anticoagulants such as warfarin, selective serotonin-reuptake inhibitors (SSRIs) or anti-platelet agents such as aspirin .<br />Hepatic: Close medical surveillance is also imperative in patients suffering from impairment of hepatic function.</p><p>Hypersensitivity reactions: As with other nonsteroidal anti-inflammatory drugs including diclofenac, allergic reactions, including anaphylactic/ anaphylactoid reactions, can also occur without earlier exposure to the drug.<br />Like other NSAIDs, EPIFENAC may mask the signs and symptoms of infection due to its pharmacodynamic properties.<br />Benzyl alcohol:This product contains benzyl alcohol which is potentially toxic when administered locally to neural tissue.<br />Precautions:<br />Cardiovascular Risk<br />NSAIDs may cause an increased risk of serious cardiovascular thrombotic events, myocardial infarction (MI), and stroke, which can be fatal.This risk may increase with duration of use.Patients with cardiovascular disease or risk factors for cardiovascular disease may be at greater risk.<br />Gastrointestinal Risk<br />NSAIDs cause an increased risk of serious gastrointestinal adverse events including bleeding, ulceration, and perforation of the stomach or intestines, which can be fatal. These events can occur at any time during use and without warning symptoms.Elderly patients are at greater risk for serious gastrointestinal (GI) events.<br />Renal:Patients with renal, cardiac or hepatic impairment and the elderly should be kept under surveillance, since the use of NSAIDs, including diclofenac may result in deterioration of renal function.The lowest effective dose should be used and renal function monitored.<br />The importance of prostaglandins in maintaining renal blood flow should be taken into account in patients with impaired cardiac or renal function, those being treated with diuretics or recovering from major surgery.Effects on renal function are usually reversible on withdrawal of EPIFENAC.<br />Hepatic:If abnormal liver function tests persist or worsen, clinical signs or symptoms consistent with liver disease develop or if other manifestations occur (eosinophilia, rash), EPIFENAC should be discontinued.Hepatitis may occur with diclofenac without prodromal symptoms.<br />Use of EPIFENAC in patients with hepatic porphyria may trigger an attack.<br />Haematological:EPIFENAC may reversibly inhibit platelet aggregation.Patients with defects of haemostasis, bleeding diathesis or haematological abnormalities should be carefully monitored.<br />Long term treatment:All patients who are receiving nonsteroidal anti-inflammatory agents should be monitored as a precautionary measure e.g.renal function, hepatic function (elevation of liver enzymes may occur) and blood counts. This is particularly important in the elderly.<br />Respiratory disorders:Like other drugs that inhibit prostaglandin synthetase activity, diclofenac sodium and other NSAIDs can precipitate bronchospasm if administered to patients suffering from, or with a previous history of bronchial asthma.<br />Cardiovascular and cerebrovascular effects:Appropriate monitoring and advice are required for patients with a history of hypertension and/or mild to moderate congestive heart failure as fluid retention and oedema have been reported in association with NSAID therapy including diclofenac.<br />Patients with uncontrolled hypertension, congestive heart failure, established ischaemic heart disease, peripheral arterial disease, and/or cerebrovascular disease should only be treated with diclofenac after careful consideration.Similar consideration should be made before initiating longer-term treatment of patients with risk factors for cardiovascular events (e.g. hypertension, hyperlipidaemia, diabetes mellitus, and smoking).<br />SLE and mixed connective tissue disease:In patients with systemic lupus erythematosus (SLE) and mixed connective tissue disorders there may be an increased risk of aseptic meningitis.<br />Dermatological:Serious skin reactions, some of them fatal, including exfoliative dermatitis, Stevens-Johnson syndrome and toxic epidermal necrolysis, have been reported very rarely in association with the use of NSAIDs, including EPIFENAC.Patients appear to be at the highest risk of these reactions early in the course of therapy, the onset of the reaction occurring in the majority of cases within the first month of treatment.EPIFENAC should be discontinued at the first appearance of skin rash, mucosal lesions or any other signs of hypersensitivity.<br />Female fertility:The use of EPIFENAC may impair female fertility and is not recommended in women attempting to conceive. In women who may have difficulties conceiving or who are undergoing investigation of infertility, withdrawal of EPIFENAC should be considered.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Lithium and digoxin:Diclofenac sodium may increase plasma concentrations of lithium and digoxin.<br />Anticoagulants:Although clinical investigations do not appear to indicate that diclofenac sodium has an influence on the effect of anticoagulants, there are isolated reports of an increased risk of haemorrhage with the combined use of diclofenac and anticoagulant therapy.Therefore, to be certain that no change in anticoagulant dosage is required, close monitoring of such patients is required.As with other nonsteroidal anti-inflammatory agents, diclofenac in a high dose can reversibly inhibit platelet aggregation.<br />Antidiabetic agents:Clinical studies have shown that diclofenac sodium can be given together with oral antidiabetic agents without influencing their clinical effect.However there have been isolated reports of hypoglycaemic and hyperglycaemic effects which have required adjustment to the dosage of hypoglycaemic agents.<br />Methotrexate:Cases of serious toxicity have been reported when methotrexate and NSAIDs including diclofenac are given within 24 hours of each other.This interaction is mediated through accumulation of methotrexate resulting from impairment of renal excretion in the presence of the NSAID.<br />Quinolone antimicrobials:Convulsions may occur due to an interaction between quinolones and NSAIDs.This may occur in patients with or without a previous history of epilepsy or convulsions.Therefore, caution should be exercised when considering the use of a quinolone in patients who are already receiving an NSAID.<br />Potent CYP2C9 inhibitors:Caution is recommended when co-prescribing diclofenac with potent CYP2C9 inhibitors (such as sulfinpyrazone and voriconazole), which could result in a significant increase in peak plasma concentrations and exposure to diclofenac due to inhibition of diclofenac metabolism.<br />Phenytoin:When using phenytoin concomitantly with diclofenac, monitoring of phenytoin plasma concentrations is recommended due to an expected increase in exposure to phenytoin.<br />Other NSAIDs including cyclooxygenase-2 selective inhibitors and corticosteroids: Co-administration of diclofenac sodium with aspirin or corticosteroids may increase the risk of gastrointestinal bleeding or ulceration.Avoid concomitant use of two or more NSAIDs.<br />Anti-platelet agents and selective serotonin reuptake inhibitors (SSRIs): Concomitant administration of systemic NSAIDs, including diclofenac may cause increased risk of gastrointestinal bleeding.<br />Diuretics: Like other NSAIDs, diclofenac sodium may inhibit the activity of diuretics. Concomitant treatment with potassium-sparing diuretics may be associated with increased serum potassium levels, which should therefore be monitored frequently.<br />Cardiac glycosides: Concomitant use of cardiac glycosides and NSAIDs in patients may exacerbate cardiac failure, reduce GFR and increase plasma glycoside levels.<br />Mifepristone: NSAIDs should not be used for 8 - 12 days after mifepristone administration as NSAIDs can reduce the effect of mifepristone.<br />Antihypertensives: Concomitant use of NSAIDs with antihypertensive drugs (i.e. beta-blockers, angiotensin converting enzyme (ACE) inhibitors, diuretics) may cause a decrease in their antihypertensive effect via inhibition of vasodilatory prostaglandin synthesis.<br />Ciclosporin and Tacrolimus: Cases of nephrotoxicity have been reported in patients receiving concomitant ciclosporin and NSAIDs, including diclofenac sodium.Possible increased risk of nephrotoxicity when NSAIDs are given with tacrolimus.This might be mediated through renal antiprostagladin effects of both NSAID and calcineurin inhibitor.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pregnancy:<br />Pregnancy: Category C.<br />Congenital abnormalities have been reported in association with the administration of NSAIDs in man, however, these are low in frequency and do not appear to follow any discernible pattern.<br />In view of the known effects of NSAIDs, including diclofenac on the foetal cardiovascular system (e.g. a premature closure of the ductus arteriosus) and in causing uterine inertia, use in the last trimester of pregnancy is contraindicated.The onset of labour may be delayed and the duration increased with an increased bleeding tendency in both mother and child.NSAIDs should not be used during the first two trimesters of pregnancy or labour unless the potential benefit outweighs the potential risk to foetus. The lowest effective dose should be used and duration kept as short as possible.<br />Lactation: Like other NSAIDs, diclofenac passes into breast milk in small amounts, therefore NSAIDs should if possible be avoided when breastfeeding.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Patients who experience dizziness, drowsiness, fatigue or visual disturbances, while taking NSAIDS should refrain from driving or operating machinery.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>If serious side-effects occur, EPIFENAC should be withdrawn.<br />Frequency estimate: frequent: &gt;10 %, occasional :&gt;1 - 10 %, rare: &gt;0.001 - 1 %, isolated cases: &lt;0.001 %.<br />Gastrointestinal tract:<br />Occasional: Epigastric pain, other gastrointestinal disorders (e.g. nausea, vomiting, diarrhoea, abdominal cramps, dyspepsia, flatulence, anorexia).<br />Rare: Gastritis, gastrointestinal bleeding (haematemesis, melaena, and bloody diarrhoea), gastrointestinal ulcers with or without bleeding or perforation (sometimes fatal, particularly in the elderly) may occur.<br />In isolated cases:Aphthous stomatitis, glossitis, oesophageal lesions, lower gut disorders (e.g. non-specific haemorrhagic colitis and exacerbations of ulcerative colitis or Crohn&#39;s proctocolitis, colonic damage and stricture formation), pancreatitis, constipation.<br />Central Nervous System disorders:<br />Occasional:Headache, dizziness, or vertigo.<br />Rare: Drowsiness, tiredness hypotension.<br />In isolated cases:Disturbances of sensation, paraesthesia, memory disturbance, disorientation, insomnia, irritability, convulsions, depression, confusion, hallucinations, malaise, anxiety, nightmares, tremor, psychotic reactions, aseptic meningitis (especially in patients with existing auto-immune disorders, such as systemic lupus erythematosus and mixed tissue disease), with symptoms such as fever, stiff neck, headache, nausea and vomiting.</p><p>Special senses:<br />Isolated cases: Disturbances of vision (blurred vision, optic neuritis, diplopia), impaired hearing, tinnitus, taste disturbances.<br />Skin:<br />Occasional:Rashes or skin eruptions.<br />Rare: Urticaria.<br />In isolated cases:Bullous eruptions, eczema, erythema multiforme, Stevens-Johnson syndrome, Lyell&#39;s syndrome, (acute toxic epidermolysis), erythroderma (exfoliative dermatitis), loss of hair, photosensitivity reactions, purpura including allergic purpura.<br />Kidney:<br />Rare: Oedema.<br />In isolated cases:Acute renal insufficiency, urinary abnormalities (e.g. haematuria, proteinuria), interstitial nephritis, nephrotic syndrome, papillary necrosis.<br />Liver:<br />Occasional:Elevation of serum aminotransferase enzymes (ALT, AST).<br />Rare: Liver function disorders including hepatitis (in isolated cases fulminant) with or without jaundice.<br />Blood:<br />In isolated cases:Thrombocytopenia, leucopenia, agranulocytosis, haemolytic anaemia, aplastic anaemia.<br />Vascular:<br />Isolated cases:Vasculitus.<br />Respiratory:<br />Isolated cases:Pneumonitis.<br />Cardiovascular system:<br />Isolated cases:Palpitations, chest pain, hypertension, congestive heart failure.<br />Other organ systems:<br />Isolated cases:Impotence.<br />Reactions to the intramuscular injection:<br />Occasional:Reactions such as local pain and induration.<br />Isolated cases:Abscesses and local necrosis at the intramuscular injection site.<br />Hypersensitivity:<br />Hypersensitivity reactions have been reported following treatment with NSAIDs. These consist of (a) non-specific allergic reactions and anaphylaxis (b) respiratory tract reactivity comprising of asthma, aggravated asthma, bronchospasm or dyspnoea, or (c) assorted skin disorders, including rashes of various types, pruritus, urticaria, purpura angiodema and, more rarely exfoliative and bullous dermatoses (including epidermal necroylsis and etheryma multiforme).<br />Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of benefit/risk balance of the medicinal product. Health care professionals are asked to report any suspected adverse reactions.</p><p>NPC Contact Information:</p><p>National pharmacovigilance &amp; Drug safety centre (NPC):</p><p>Fax: +966-11-205-7662.<br />Call NPC at +966-11-2038222, Exts: 2317-2356-2353-2354-2334-2340.<br />Toll free phone: 8002490000.<br />E-mail: npc.drug@sfda.gov.sa.<br />Website: www.sfda.gov.sa/npc.</p><p>Other GCC States:</p><p>Please contact the relevant competent authority.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Symptoms:Symptoms include headache, nausea, vomiting, epigastric pain, gastrointestinal bleeding, rarely diarrhoea, disorientation, excitation, coma, drowsiness, tinnitus, fainting, occasionally convulsions.In rare cases of significant poisoning acute renal failure and liver damage are possible.<br />Therapeutic measures:Patients should be treated symptomatically as required.Within one hour of ingestion of a potentially toxic amount, activated charcoal should be considered.Alternatively, in adults gastric lavage should be considered within one hour of ingestion of potentially toxic amounts.Frequent or prolonged convulsions should be treated with intravenous diazepam.Other measures may be indicated by the patients clinical condition.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group:Nonsteroidal anti-inflammatory drugs (NSAIDs).<br />Mechanism of action:<br />EPIFENAC is a nonsteroidal agent with marked analgesic/anti- inflammatory properties. It is an inhibitor of prostaglandin synthetase, (cyclo-oxygenase).<br />Diclofenac sodium in vitro does not suppress proteoglycan biosynthesis in cartilage at concentrations equivalent to the concentrations reached in human beings.When used concomitantly with opioids for the management of post-operative pain, EPIFENAC often reduces the need for opioids.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Absorption:<br />Ampoules:After administration of 75 mg diclofenac by intramuscular injection, absorption sets in immediately, and mean peak plasma concentrations of about 2.558 &plusmn; 0.968 &mu;g/ml (2.5 &mu;g/mL &Xi; 8 &mu;mol/L) are reached after about 20 minutes.The amount absorbed is in linear proportion to the size of the dose.<br />Intravenous infusion: When 75 mg diclofenac is administered as an intravenous infusion over 2 hours, mean peak plasma concentrations are about 1.875 &plusmn; 0.436 &mu;g/ml (1.9 &mu;g/ml &Xi; 5.9 &mu;mol/L).Shorter infusions result in higher peak plasma concentrations, while longer infusions give plateau concentrations proportional to the infusion rate after 3 to 4 hours.This is in contrast to the rapid decline in plasma concentrations seen after peak levels have been achieved with oral, rectal or i.m. administration.<br />Bioavailability:<br />About half of the administered diclofenac is metabolised during its first passage through the liver (&quot;first-pass&quot; effect), the area under the concentrations curve (AUC) following oral and rectal administrations is about half that following an equivalent parenteral dose.</p><p>Pharmacokinetic behaviour does not change on repeated administration.Accumulation does not occur, provided the recommended dosage intervals are observed.<br />The plasma concentrations attained in children given equivalent doses (mg/kg, b.w.) are similar to those obtained in adults. (25 mg tablet, and 12.5 mg and 25 mg suppositories only)<br />Distribution:<br />The active substance is 99.7% protein bound, mainly to albumin (99.4%).<br />Diclofenac enters the synovial fluid, where maximum concentrations are measured 2 - 4 hours after the peak plasma values have been attained. The apparent half-life for elimination from the synovial fluid is 3 - 6 hours. Two hours after reaching the peak plasma values, concentrations of the active substance are already higher in the synovial fluid than they are in the plasma and remain higher for up to 12 hours.<br />Metabolism:<br />Biotransformation of diclofenac takes place partly by glucuronidation of the intact molecule, but mainly by single and multiple hydroxylation and methoxylation, resulting in several phenol ic metabolites, most of which are converted to glucuronide conjugates. Two phenolic metabolites are biologically active, but to a much lesser extent than diclofenac.<br />Elimination:<br />The total systemic clearance of diclofenac in plasma is 263 &plusmn; 56 ml/min (mean value &plusmn; SD). The terminal half-life in plasma is 1 - 2 hours. Four of the metabolites, including the two active ones, also have short plasma half-lives of 1 - 3 hours.<br />About 60% of the administered dose is excreted in the urine in the form of the glucuronide conjugate of the intact molecule and as metabolites, most of which are also converted to glucuronide conjugates.Less than 1% is excreted as unchanged substance. The rest of the dose is eliminated as metabolites through the bile in the faeces.<br />Characteristics in patients:<br />Elderly:No relevant age-dependent differences in the drug&#39;s absorption, metabolism, or excretion have been observed, other than the finding that in five elderly patients, a 15 minute iv infusion resulted in 50% higher plasma concentrations than expected with young healthy subjects.<br />Patients with renal impairment:In patients suffering from renal impairment, no accumulation of the unchanged active substance can be inferred from the single-dose kinetics when applying the usual dosage schedule.At a creatinine clearance of &lt;10 mL/min, the calculated steady-state plasma levels of the hydroxy metabolites are about 4 times higher than in normal subjects.However, the metabolites are ultimately cleared through the bile.<br />Patients with hepatic disease:In patients with chronic hepatitis or non-decompensated cirrhosis, the kinetics and metabolism of diclofenac are the same as in patients without liver disease.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>None known.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Propylene glycol, sodium metabisulphite, benzyl alcohol, mannitol, sodium hydroxide, water for injection.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>None known.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                3 years (36 months).
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Store at temperature not exceeding 30&deg; C.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>EPIFENAC Ampoules: Box of 3 amber glass ampoules.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No special instructions.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Egyptian International Pharmaceutical Industries Company, E.I.P.I.CO., Egypt
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                June 2015
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>